SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending after announcing a non-exclusive license agreement with Pfizer for its Matrix-M adjuvant, providing significant validation for the technology. This deal, building on previous collaborations, is driving community excitement and fueling discussions about the adjuvant's potential applications and the company's future partnerships amidst notable short interest.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is driving significant conversation as escalating US-EU trade tensions, particularly over Greenland and proposed tariffs, spark widespread market uncertainty and a risk-off shift. The community is sharply divided, with intense debate over whether current volatility signals a deeper correction or presents a key buying opportunity amidst ongoing institutional interest and broader macroeconomic shifts.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is generating significant buzz following positive regulatory advancements for its ANKTIVA therapy, with the FDA outlining a path to resubmission for papillary bladder cancer that requires no new clinical trials. This news, combined with recent international approvals, is fueling strong community sentiment around the potential for a "cancer cure" and intense discussions anticipating a substantial short squeeze.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is currently a major talking point among investors, primarily driven by its upcoming earnings report and the proposed all-cash acquisition of Warner Bros. Discovery assets, which has sparked a debate over potential growth versus debt concerns. The community is closely watching for strong ad-tier performance and subscriber metrics, particularly after a previous tax-related earnings miss, with sentiment split on whether recent oversold conditions signal a significant rebound or continued volatility.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as market participants react to heightened geopolitical tensions, specifically former President Trump's recent tariff threats against NATO allies over Greenland and an anticipated Supreme Court ruling on presidential tariff authority. This has sparked a fierce debate among investors, with some advocating to "buy the dip" and anticipating a rapid "Taco Trade" rebound, while others warn of a significant market correction. Adding to the volatility are concerns surrounding Japan's bond market instability, creating a complex and uncertain trading environment.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is currently experiencing a significant surge, fueled by an intense Arctic air invasion across the United States that is driving up natural gas demand and futures prices. The strong upward momentum has triggered a notable short squeeze, with the community actively discussing substantial profits and anticipating continued upside as extreme cold weather is projected to persist. This volatility is characteristic of the 2x leveraged ETF, attracting both profit-takers and those eyeing further gains.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is experiencing significant volatility amid escalating geopolitical tensions, notably the US asserting control over Venezuela's oil and ongoing debates surrounding US tariffs, fueling a "flight to quality" narrative for some. The community is actively discussing whether these events, alongside large institutional bond purchases, will continue to boost Treasuries as a safe haven or intensify concerns over US debt and the Federal Reserve's independence.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin ($APP) is experiencing significant volatility and a notable price decline following a new short report alleging the company's involvement in money laundering. This report has sparked intense debate among investors, with many attributing the drop to market manipulation and viewing it as a buying opportunity, while others express concern over the serious accusations despite recent bullish analyst upgrades.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to overwhelmingly positive data from its Phase 1 clinical trial of soquelitinib for atopic dermatitis, with community discussions highlighting its strong efficacy in treatment-resistant patients. Investors are actively debating the potential for this novel oral ITK inhibitor to disrupt the significant atopic dermatitis market, fueling speculation of future partnerships or an acquisition and validating its broader immune-modulating platform.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares ETF (GLD) is trending strongly as renewed geopolitical tensions, including recent tariff threats concerning European countries over Greenland, fuel a broad flight to safety. The community views gold as a crucial hedge against eroding fiat currency confidence and economic instability, driving prices to consistent new highs. Many are discussing significant further appreciation as these global uncertainties persist.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Oppenheimer said that a challenging operating environment due to the artificial intelligence technology transition has led to “uninspiring and decelerating top-line growth.”&nbsp;</li><li>However, the analyst added that Adobe has good medium-term opportunities and is a cheap stock.&nbsp;</li><li>Earlier, Goldman Sachs assumed coverage of Adobe with a ‘Sell’ rating and a price target of $290.</li></ul>Shares of Adobe Inc. (ADBE) declined nearly 6% on Tuesday after Oppenheimer downgraded the stock to ‘Perform’ from Outperform, without a price target, However, retail traders continue to stay bullish on the stock.Analyst Brian Schwartz at Oppenheimer said that a challenging operating environment due to the artificial intelligence technology transition has led to “uninspiring and decelerating top-line-growth,” according to TheFly.The analyst added that inconsistent execution with product cycles, durability concerns about the moat, lackluster investor interest for owning software names, and year-over-year operating margin guidance in FY26 will likely weigh negatively on the sentiment for the company's opportunities this year, and limit near-term upside for the shares.Shares of ADBE were trading around $308.06 at the time of writing, the lowest it has been in over three years.<h2 class="st-heading-2">Street Consensus</h2>Oppenheimer had previously been bullish on Adobe, expecting its AI business to boost growth in its digital media segment. However, the analyst noted that it did not play out as expected and growth in the digital media growth decelerated further in FY25.However, the analyst added that Adobe has good medium-term opportunities and is a cheap stock.Earlier, Goldman Sachs assumed coverage of Adobe with a ‘Sell’ rating and a price target of $290. The analyst noted that Adobe's high-end seat count is under pressure as value accrues at the low-end where the company has minimal exposure.Adobe’s consensus rating, which indicates the ratio of buy, hold, and sell ratings from analysts, is at 3.73, down from 4 in December 2025, as per data from Koyfin. 22 of 40 analysts still have a rating of ‘Buy’ or higher on the stock.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_14_at_12_48_07_AM_png_93d2f946b3.webp" alt="Adobe’s consensus rating, which indicates the ratio of buy, hold, and sell ratings from analysts, is at 3.73, down from 4 in December 2025, as per data from Koyfin." width="913" height="772"></figure><h2 class="st-heading-2">How Are Stocktwits Users Reacting?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/ADBE">ADBE stock</a> jumped to ‘bullish’ from ‘bearish’ territory over the past 24 hours amid ‘high’ message volumes. Despite the downturn, some retail investors are still bullish on the stock, seeing an attractive long-term opportunity.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_14_at_12_49_42_AM_png_84db19bff6.webp" alt="On Stocktwits, retail sentiment around ADBE stock jumped to ‘bullish’ from ‘bearish’ territory over the past 24 hours amid ‘high’ message volumes." width="1278" height="154"></figure>&nbsp;One user called Adobe ‘the best creative software in the market’, adding that they would be buying more shares.<stembedurl>https://stocktwits.com/Kaizen777/message/641681297</stembedurl>&nbsp;Another bullish user pointed out that the company has been increasingly buying back its own shares, indicating its confidence.<stembedurl>https://stocktwits.com/2ktrading/message/641686631</stembedurl>&nbsp;Shares of ADBE are down over 24% in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

A sign is posted on the exterior of an Adobe office on December 10, 2025 in San Francisco, California. Software maker Adobe will report fourth-quarter earnings today after the closing bell. 

ADBE Shares Slip On Analyst Downgrades — But Why Is Retail Bullish?

Adobe shares declined on Tuesday after Oppenheimer downgraded the stock to ‘Perform’ from Outperform, without a price target. 

Equity

Vanguard Growth ETF Portfolio (TSE:VGRO) Hits New 1-Year High - Still a Buy?

Vanguard Growth ETF Portfolio (TSE:VGRO) Reaches New 1-Year High - Here's What Happened...

Vanguard Growth ETF Portfolio (TSE:VGRO) Hits New 52-Week High - Still a Buy?

Vanguard Growth ETF Portfolio (TSE:VGRO) Sets New 12-Month High - Time to Buy...

VUG Fundamental Analysis

Below is Validea's ETF fundamental report for Vanguard Growth ETF (VUG). The report looks at VUG's exposure to the major investing factors including value, quality, momentum and low volatility...

Will the Ongoing Market Rally Continue in 2026? ETFs in Focus

S&P 500 momentum and retail inflows set the stage for a potential 2026 rally, with ETFs offering ways to ride the bullish trend.

VUG vs. VOOG: Which of These Vanguard Growth ETFs Is Best for Investors?

Key PointsVUG is far larger and more liquid than VOOG, but carries slightly higher volatility and a deeper five-year drawdown...

Vanguard Growth ETF vs. Vanguard Value ETF: Which ETF Will Outperform in 2026?

Key PointsGrowth stocks are set to outperform value stocks once again in 2025...

ETFs to Keep Your Portfolio on Track in the Long Term

Despite November's volatility, optimism is returning to Wall Street. Discover how long-term strategies combined with ETFs can help investors build resilient portfolios ready to capture the next phase of the bull market.

S&P 500 Stability vs. Superior Growth: Is VOO or VUG the Better ETF for You?

Key PointsThe Vanguard Growth ETF boasts higher recent returns and greater tech sector exposure, while the Vanguard S&P 500 ETF spreads risk more broadly across 500 companies...

Prediction: This Unstoppable Vanguard ETF Will Crush the S&P 500 (Again) in 2026

Key PointsThe S&P 500 is having a strong year in 2025, but investors who own the Vanguard Growth ETF are doing even better...

Current Price	$485.09
Prev Close	$485.59
Open	$487.64
Dividend Yield	N/A
50-Day Moving Average	$487.44
Beta	N/A
Avg. Volume	948,792.32
PE Ratio	N/A

52-Week High	$505.38
52-Week Low	$316.14
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

VUG
Vanguard Growth ETF

Feed

News

Sentiment

Fundamentals

Info

Latest VUG News

VUGVanguard Growth ETF